PDF Vertex ups cystic fibrosis sales view, but 2 trials fail | Reuters 2 Min Read (Reuters) - NASDAQ-NMS:VRTX Vertex Pharmaceuticals Inc ( VRTX.O ) raised its outlook for full-year sales of its cystic fibrosis drugs as it released quarterly earnings on Wed
| EVENT DAY Stock performance from the time of news release until the following 4pm ET market close | LAST PRICE AT NEWS EVENT | SINCE EVENT Multi-day stock performance from the time of the news release |
|---|---|---|
| EVENT DAY Stock performance from the time of news release until the following 4pm ET market close | LAST PRICE AT NEWS EVENT | SINCE EVENT Multi-day stock performance from the time of the news release |
| LAST PRICE | ||
| VWAP | ||
| High: | MAX UP | High: |
| Low: | MAX DOWN | Low: |
| % | POST NEWS RANGE | % |
| PRICE CHANGE | ||
| PRICE CHANGE PERCENTAGE | ||
| S&P 500 (SPX) | ||
| % | VOLUME RATIO | % |
| VOLUME (SHARES) | ||
| TICKS | ||
| AVG SHARES PER TRADE |
More